Product Usage: This product is intended for research purposes only.
All product information available on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. This product should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
5-Amino-1MQ (50mg/capsule), 60 Capsules
During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly same as standards.
5-Amino-1MQ (5-Amino-1-methylquinolinium iodide) is a selective small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in nicotinamide methylation and cellular methyl-donor utilization pathways. By inhibiting NNMT activity, 5-Amino-1MQ modulates enzymatic processes associated with nicotinamide metabolism, methylation network regulation, and intracellular cofactor-associated signaling systems. Experimental investigations have examined the relationship between NNMT inhibition and regulatory pathways involving nicotinamide turnover, methylation dynamics, transcriptional control mechanisms, and downstream signal transduction processes.
Its well-characterized pharmacological profile has established 5-Amino-1MQ as a valuable research tool for studying NNMT enzyme biology, enzyme-inhibitor interactions, methylation pathway regulation, nicotinamide-associated metabolic networks, and structure-activity relationships involving NNMT-targeting compounds. Research applications include NNMT pharmacology, methyltransferase signaling studies, enzymatic regulation investigations, and mechanistic evaluation of nicotinamide methylation pathways.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
3D Molecular Structure
Drag to rotate · scroll to zoom| Chemical Formula | C10H11IN2+ |
|---|---|
| Synonyms | 5-amino-1-methylquinolinium, SCHEMBL6403148 CHEMBL4116828, ZINC552049, STL196667 |
| Molar Mass | 159.21 g/mol |
| CAS Number | 42464-96-0 |
| PubChem CID | 950107 |
| Total Compound Content | 3,000 mg (50 mg per capsule) |
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
What enzyme does 5-Amino-1MQ inhibit?
5-Amino-1MQ selectively inhibits nicotinamide N-methyltransferase (NNMT), a methyltransferase enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide, producing 1-methylnicotinamide. Because NNMT occupies a central position within nicotinamide methylation pathways, it has become an important target for investigations involving enzyme regulation, methyl-donor utilization, cofactor-associated signaling networks, and methyltransferase pharmacology.
How does 5-Amino-1MQ differ from compounds such as NMN and NR in pathway research?
NMN and NR are commonly studied in relation to nicotinamide-associated metabolic pathways, whereas 5-Amino-1MQ acts through selective inhibition of NNMT. This distinct mechanism makes 5-Amino-1MQ a useful research tool for examining enzymatic regulation of nicotinamide turnover, methylation pathway dynamics, enzyme-inhibitor interactions, and regulatory processes associated with NNMT activity. Comparative investigations frequently utilize these compounds to explore different aspects of nicotinamide-related biochemical networks.
Why is 5-Amino-1MQ widely used in NNMT research?
5-Amino-1MQ possesses a well-characterized pharmacological profile and high selectivity for NNMT, making it a valuable reference compound for studies involving NNMT enzyme biology, methyltransferase pathway regulation, structure-activity relationships, and inhibitor-target interactions. Its established mechanism of action continues to support mechanistic investigations into nicotinamide methylation pathways and the broader role of NNMT within cellular regulatory networks.
